Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA study of prediction model-guided duration of vitamin K antagonist therapy after first unprovoked venous thromboembolism
NL-OMON25558Not yet recruiting
- Sponsor
- Utrecht University
- Start
- Aug 2011
- Countries
- 1
01
Overview
Randomised, open-label trial in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) (2 arms), sponsored by Utrecht University. Primary endpoint: Recurrent venous thromboembolism. Planned start Aug 2011; status: not yet recruiting.
02
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NL-OMON25558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25558.